Series A · Biotech · Paris, France · Founded 2020 · 11–50 employees
Qubit Pharmaceuticals is a Paris-based deep tech company specializing in the discovery and design of new drug candidates for complex targets, including RNA, by leveraging advanced molecular simulation, hybrid high-performance computing, and quantum computing technologies. Founded in 2020, the company raised €16 million in 2022 to accelerate its groundbreaking research and development.